How Pharma Data Science is Transforming Drug Discovery–Insights from a CSO!

In this episode, we dive deep into the world of pharma data science with Dr. Ben Sidders, Chief Science Officer at Biorelate. With two decades of experience in drug discovery, including roles at AstraZeneca and Pfizer, Dr. Sidders shares his journey, insights, and the cutting-edge advancements Biorelate is making in computational oncology and immuno-oncology. Learn how bioinformatics is reshaping drug discovery and the biggest challenges and opportunities facing the industry today. Plus, Dr. Sidders reveals the greatest leadership advice he's received and what truly inspires, concerns, and excites him in this rapidly evolving field.